-
1 Comment
Wai Yuen Tong Medicine Holdings Limited is currently in a long term downtrend where the price is trading 6.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Wai Yuen Tong Medicine Holdings Limited's total revenue sank by 17.4% to $155M since the same quarter in the previous year.
Its net income has increased by 28.4% to $24M since the same quarter in the previous year.
Finally, its free cash flow fell by 4.4% to $-11M since the same quarter in the previous year.
Based on the above factors, Wai Yuen Tong Medicine Holdings Limited gets an overall score of 2/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | BMG9421Y2332 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 416M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | 8.2% |
| Beta | 0.42 |
Wai Yuen Tong Medicine Holdings Limited, an investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong. The company manufactures, processes, and sells traditional Chinese medicines under the brand Wai Yuen Tong brand and western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also invests in commercial and industrial premises for rental. Wai Yuen Tong Medicine Holdings Limited was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. The company is a subsidiary of Rich Time Strategy Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0897.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
